News + Filings Transactions
|
GV 2017 GP, L.L.C.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 243 | $32.90 | $8k | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 650 | $31.99 | $20.8k | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 47.7k | $31.12 | $1.5M | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 242 | $32.90 | $8k | By Alphabet Holdings LLC | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 651 | $31.99 | $20.8k | By Alphabet Holdings LLC | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 47.7k | $31.12 | $1.5M | By Alphabet Holdings LLC | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Other (disposition) | Common Stock | 48.6k | $0.00 | $0 | By GV 2017 L.P. | 11/04/2022 |
| 10/18/2021 | Gitlab Inc. | | Conversion | Series C Preferred Stock | 8.4M | $0.00 | $0 | By GV 2017, L.P. | 10/18/2021 |
| 10/18/2021 | Gitlab Inc. | | Conversion | Series D Preferred Stock | 514.7k | $0.00 | $0 | By GV 2017, L.P. | 10/18/2021 |
| 10/18/2021 | Gitlab Inc. | | Conversion | Class B Common Stock | 8.9M | $0.00 | $0 | By GV 2017, L.P. | 10/18/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 6.3M | $0.00 | $0 | By GV 2017, L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 58.5M | $0.00 | $0 | By GV 2017, L.P. | 06/21/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 494.6k | $0.00 | $0 | By GV 2017, L.P. | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series C Preferred Stock | 6.2M | $0.00 | $0 | By GV 2017, L.P. | 02/17/2021 |
| 03/19/2018 | Arcus Biosciences, Inc. | RCUS | Conversion | Common Stock | 1.9M | $0.00 | $0 | By GV 2017, L.P. | 03/19/2018 |
| 03/19/2018 | Arcus Biosciences, Inc. | RCUS | Conversion | Series C Convertible Preferred Stock | 1.9M | $0.00 | $0 | By GV 2017, L.P. | 03/19/2018 |
|